Brief: 4D Molecular Therapeutics Q3 Net Income USD -10.256 Million
09/11/2023 21:20
Nov 09 (Reuters) - 4D Molecular Therapeutics Q3 basic EPS USD -0.24. * Q3 operating income USD -13.974 million * Q3 operating expenses USD 34.178 million * Q3 revenue USD 20.204 million vs. IBES estimate USD 8.03 million * Q3 EPS USD -0.24
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings